For peer-reviewed articles for supportive care physicians
Click here »
For peer-reviewed articles for clinical oncology physicians
Click here »
| 8th Annual Chicago Supportive Oncology ConferenceOctober 26-27, 2012 Hotel InterContinental |
|---|
| |
Abbott Nutrition, makers of Ensure and Glucema, is a worldwide leader in providing innovative nutritional produtcs that help improve the quality of life and outcomes for patients. Nutrition intervention can help cancer patients maintain a healthy weight, better tolerate treatment and minimize treatment disruptions. Please stop by our booth to learn more about how Perscribing Nutrition can help you see your patients through the full course of treatment. www.abbottnutrition.com
| |
| |
Amgen, a biotechnology pioneer, discovers, develops, and delivers innovative human therapeutics. Our medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance to serve patients.
| |
| |
Cangene is one of the worlds' leading biopharmaceutical companies, focusing on the development, manufacture and commericialization of therapies targeting infectious disease, hematology/oncology and transplantation. episil- Oral liquid represents a new concept for the treatment of pain resulting from oral mucositis. episil is supplied in a 10mL ready to sue bottle for patients with oral mucositis that has resulted from chemotherapy and radiaition therapy.
| |
| |
Helsinn is a privately owned pharmaceutical group with headquarters in Lugano Swittzerland and additonal locations in Ireland and Bridgewater, New Jersey, USA. The Helsinn Group has been built on the basis of a unique business model focused on the in - and out- licensing of pharmaceuticals and medical devices in therapeutic niche areas. Helsinn is dedicated to developing important products in Cancer Supportive Care. Helsinn in-licenses early to late stage new chemical entities, completes their development from the performance of preclinical and clinical studies of chemistry, manufacturing and control (CMC), all the way through the attainment of market approvals worldwide. Following approval, Helsinn will market the products directly through its own US affiliate, Helsinn Therapeutics, or through its netwrok of local pharmaceutical partners, selected for their deep in-market knowledge and know-how, and assisted and supported with a full range of product and scientific managemenet services. | |
|
| |
| |
INSYS Therapeutics is a specialty pharmaceutical company that develops innovative products that target unmet patient needs. Our products include a proprietary sublingual fentanyl spray for treatment of breakthrough cancer pain and dronabinol products for the treatment of CINV. We focus on products that address the clinical shortcomings of existing products.
| |
| |
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies and consumer and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. For more inforamtion visit www.merck.com
| |
| |
ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. | |
|
